| An economic evaluation of a laboratory monitoring program for Renin-Angiotensin system agents. | |
| | |
MedLine Citation:
|
PMID: 21393563 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: The efficiency of patient safety interventions is not well studied, especially laboratory monitoring for drug therapy. More than one-third of preventable adverse drug events are associated with inadequate monitoring. Current knowledge of decreasing adverse drug events through expanded monitoring programs is lacking. DESIGN: . The authors focused on a laboratory monitoring program (above usual practice) of renin-angiotensin system (RAS) agents to prevent adverse events of hyperkalemia and acute renal failure. They used a probabilistic decision model to estimate cost savings and cost effectiveness (at $30,000 and $10,000 per quality-adjusted life-year (QALY)). Costs included the monitoring program, and offsets from reduced care in 3 populations (overall, chronic kidney disease [CKD], and diabetes). Main results. Adverse events were most common in those with CKD. Intervening on all new users or the subset with diabetes was almost never expected to be cost saving (probability <1%). But a monitoring program restricted to patients with CKD was expected to be cost saving (probability = 95%). A strategy that intervened on all patients, or those with diabetes, was never cost effective, (probability <1%). But intervening on patients with CKD was estimated to be cost effective (at either cost-effectiveness threshold) at least 95% of the time in the base case. CONCLUSIONS: . The authors' findings illustrate that for laboratory monitoring to be cost effective, the patient population must be at high enough risk of adverse events. Further inquiry into the willingness to pay for patient safety interventions is needed. |
| | |
Authors:
|
David H Smith; Marsha A Raebel; K Arnold Chan; Eric S Johnson; Amanda F Petrik; Jessica R Weiss; Xiuhai Yang; Adrianne Feldstein |
Related Documents
:
|
3857393 - The assessment of bulimia in high school students. 20817023 - Emerging tobacco products: hookah use among new jersey youth. 8648273 - Transition to living: the neglected component of transition programming for individuals... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Medical decision making : an international journal of the Society for Medical Decision Making Volume: 31 ISSN: 1552-681X ISO Abbreviation: Med Decis Making Publication Date: 2011 Mar-Apr |
Date Detail:
|
Created Date: 2011-03-11 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8109073 Medline TA: Med Decis Making Country: United States |
Other Details:
|
Languages: eng Pagination: 315-24 Citation Subset: IM |
Affiliation:
|
Center for Health Research, Kaiser Permanente Northwest, Portland, OR (DHS, ESJ, AFP, JRW, XY, AF). |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Use of a Catalytic Model to Estimate Hepatitis A Incidence in a Low-Endemicity Country: Implications...
Next Document: Reversals of association for Pap, colorectal, and prostate cancer testing among Hispanic and non-His...